GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Fresenius SE & Co KGaA (OTCPK:FSNUY) » Definitions » Cyclically Adjusted PS Ratio

Fresenius SE KGaA (Fresenius SE KGaA) Cyclically Adjusted PS Ratio : 0.41 (As of Apr. 29, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Fresenius SE KGaA Cyclically Adjusted PS Ratio?

As of today (2024-04-29), Fresenius SE KGaA's current share price is $7.465. Fresenius SE KGaA's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 was $18.38. Fresenius SE KGaA's Cyclically Adjusted PS Ratio for today is 0.41.

The historical rank and industry rank for Fresenius SE KGaA's Cyclically Adjusted PS Ratio or its related term are showing as below:

FSNUY' s Cyclically Adjusted PS Ratio Range Over the Past 10 Years
Min: 0.32   Med: 0.73   Max: 1.59
Current: 0.41

During the past years, Fresenius SE KGaA's highest Cyclically Adjusted PS Ratio was 1.59. The lowest was 0.32. And the median was 0.73.

FSNUY's Cyclically Adjusted PS Ratio is ranked better than
76.81% of 332 companies
in the Healthcare Providers & Services industry
Industry Median: 1.19 vs FSNUY: 0.41

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio. The Cyclically Adjusted Revenue per Share is the average of the inflation adjusted revenue per share of a company over the past 10 years.

Fresenius SE KGaA's adjusted revenue per share data for the three months ended in Dec. 2023 was $2.748. Add all the adjusted revenue per share for the past 10 years together and divide 10 will get our Cyclically Adjusted Revenue per Share, which is $18.38 for the trailing ten years ended in Dec. 2023.

Shiller PE for Stocks: The True Measure of Stock Valuation


Fresenius SE KGaA Cyclically Adjusted PS Ratio Historical Data

The historical data trend for Fresenius SE KGaA's Cyclically Adjusted PS Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Fresenius SE KGaA Cyclically Adjusted PS Ratio Chart

Fresenius SE KGaA Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PS Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.01 0.72 0.61 0.41 0.42

Fresenius SE KGaA Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Cyclically Adjusted PS Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.41 0.38 0.38 0.44 0.42

Competitive Comparison of Fresenius SE KGaA's Cyclically Adjusted PS Ratio

For the Medical Care Facilities subindustry, Fresenius SE KGaA's Cyclically Adjusted PS Ratio, along with its competitors' market caps and Cyclically Adjusted PS Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Fresenius SE KGaA's Cyclically Adjusted PS Ratio Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Fresenius SE KGaA's Cyclically Adjusted PS Ratio distribution charts can be found below:

* The bar in red indicates where Fresenius SE KGaA's Cyclically Adjusted PS Ratio falls into.



Fresenius SE KGaA Cyclically Adjusted PS Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PS Ratio takes the Revenue per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/S calculation. Because it considers this 10-year average, it's often referred to as the CAPS Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PS Ratio.

Fresenius SE KGaA's Cyclically Adjusted PS Ratio for today is calculated as

Cyclically Adjusted PS Ratio=Share Price/ Cyclically Adjusted Revenue per Share
=7.465/18.38
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Fresenius SE KGaA's Cyclically Adjusted Revenue per Share for the quarter that ended in Dec. 2023 is calculated as:

For example, Fresenius SE KGaA's adjusted Revenue per Share data for the three months ended in Dec. 2023 was:

Adj_RevenuePerShare=Revenue per Share/CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=2.748/123.6675*123.6675
=2.748

Current CPI (Dec. 2023) = 123.6675.

Fresenius SE KGaA Quarterly Data

Revenue per Share CPI Adj_RevenuePerShare
201403 3.304 99.543 4.105
201406 3.403 99.543 4.228
201409 3.552 99.823 4.400
201412 3.679 99.543 4.571
201503 3.201 99.717 3.970
201506 3.532 100.417 4.350
201509 3.539 100.417 4.358
201512 3.594 99.717 4.457
201603 3.544 100.017 4.382
201606 3.687 100.717 4.527
201609 3.760 101.017 4.603
201612 3.739 101.217 4.568
201703 4.000 101.417 4.878
201706 4.306 102.117 5.215
201709 4.425 102.717 5.328
201712 4.606 102.617 5.551
201803 4.483 102.917 5.387
201806 4.385 104.017 5.213
201809 4.270 104.718 5.043
201812 4.501 104.217 5.341
201903 4.298 104.217 5.100
201906 4.458 105.718 5.215
201909 4.324 106.018 5.044
201912 4.629 105.818 5.410
202003 4.519 105.718 5.286
202006 4.513 106.618 5.235
202009 4.702 105.818 5.495
202012 5.066 105.518 5.937
202103 4.786 107.518 5.505
202106 4.993 108.486 5.692
202109 4.914 109.435 5.553
202112 5.041 110.384 5.648
202203 4.792 113.968 5.200
202206 4.700 115.760 5.021
202209 2.367 118.818 2.464
202212 2.666 119.345 2.763
202303 4.859 122.402 4.909
202306 5.261 123.140 5.284
202309 2.611 124.195 2.600
202312 2.748 123.668 2.748

Add all the adjusted revenue per share together and divide 10 will get our Cyclically Adjusted Revenue per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Fresenius SE KGaA  (OTCPK:FSNUY) Cyclically Adjusted PS Ratio Explanation

Compared with the regular PS Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PS Ratio smoothed out the fluctuations of revenue during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PS Ratio should give similar results to regular PS Ratio.


Fresenius SE KGaA Cyclically Adjusted PS Ratio Related Terms

Thank you for viewing the detailed overview of Fresenius SE KGaA's Cyclically Adjusted PS Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Fresenius SE KGaA (Fresenius SE KGaA) Business Description

Address
Else-Kroener-Strasse 1, Bad Homburg, HE, DEU, 61352
Fresenius SE is a healthcare holding company based in Germany with four segments. The company owns a large stake in dialysis service provider and equipment manufacturer Fresenius Medical Care. The Kabi segment manufactures intravenous drugs, nutrition products, infusion and transfusion therapies, and related pumps. The Helios segment operates private hospitals and fertility clinics in Germany, Spain, and Latin America. Vamed provides a variety of services such as healthcare facility construction and operation management, including post-acute care rehabilitation.

Fresenius SE KGaA (Fresenius SE KGaA) Headlines

From GuruFocus

Top 1st-Quarter Trades of the Tweedy Browne Global Value Fund

By Margaret Moran Margaret Moran 04-13-2021

Tweedy Browne Fund's 1st-Quarter Commentary

By Sydnee Gatewood Sydnee Gatewood 05-04-2021

Tweedy Browne Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood 06-01-2021

Tweedy Brown Comments on Fresenius

By Sydnee Gatewood Sydnee Gatewood 05-04-2021